Kruk Emilia, Krasnodębski Maciej, Rykowski Paweł, Figiel Wojciech, Hołówko Wacław, Raszeja-Wyszomirska Joanna, Grąt Michał
Department of General Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
Liver and Internal Medicine Unit, Department of General Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
Ann Transplant. 2025 Jan 28;30:e946485. doi: 10.12659/AOT.946485.
BACKGROUND Acute liver failure (ALF) remains a critical concern, accounting for about 8% of all liver transplants, with acetaminophen overdose contributing to nearly half of these cases. Besides synthetic toxins, natural toxins such as phallotoxin from Amanita phalloides mushrooms also lead to severe hepatocyte damage. This study investigates the outcomes of liver transplantation (LT) as a life-saving intervention in patients suffering from ALF due to acetaminophen and Amanita phalloides poisoning. MATERIAL AND METHODS We conducted a retrospective analysis of 39 patients who underwent LT for ALF induced by acetaminophen (n=18) or A. phalloides (n=21) poisoning at the Medical University of Warsaw. Various statistical analyses, including logistic regression, Mann-Whitney-U, and chi-squared tests, were employed. Survival rates were determined using Kaplan-Meier analysis. RESULTS The cohort included 24 females and 15 males, with a median age of 41. The 90-day mortality rate was 22.2% for acetaminophen poisoning and 38.1% for A. phalloides poisoning (P=0.284), with an estimated 5-year survival rate of 59.6%. Key factors associated with increased 90-day mortality included the number of red blood cells transfused (OR 1.574 per unit; P=0.011), fresh frozen plasma units (OR 1.346 per unit; P=0.003), acute kidney failure requiring hemodialysis (OR 13.50; P=0.021), and days from listing to LT (OR 2.289 per day; P=0.013). CONCLUSIONS Liver transplantation for ALF, though inherently high-risk, offers substantial survival benefits. Outcomes are largely influenced by the patient's condition at the time of transplant, organ availability, and intraoperative management. Despite significant mortality risks, LT remains a crucial intervention for ALF due to acetaminophen and Amanita phalloides toxicity.
急性肝衰竭(ALF)仍是一个关键问题,约占所有肝移植病例的8%,其中对乙酰氨基酚过量导致了近一半的此类病例。除了合成毒素外,来自毒蝇伞蘑菇的鬼笔毒素等天然毒素也会导致严重的肝细胞损伤。本研究调查了肝移植(LT)作为一种挽救生命的干预措施,用于治疗因对乙酰氨基酚和毒蝇伞中毒导致急性肝衰竭患者的疗效。
我们对在华沙医科大学因对乙酰氨基酚(n = 18)或毒蝇伞(n = 21)中毒导致急性肝衰竭而接受肝移植的39例患者进行了回顾性分析。采用了各种统计分析方法,包括逻辑回归、曼-惠特尼-U检验和卡方检验。使用Kaplan-Meier分析确定生存率。
该队列包括24名女性和15名男性,中位年龄为41岁。对乙酰氨基酚中毒患者的90天死亡率为22.2%,毒蝇伞中毒患者为38.1%(P = 0.284),估计5年生存率为59.6%。与90天死亡率增加相关的关键因素包括输注红细胞的数量(每单位OR 1.574;P = 0.011)、新鲜冰冻血浆单位数(每单位OR 1.346;P = 0.003)、需要血液透析的急性肾衰竭(OR 13.50;P = 0.021)以及从列入名单到肝移植的天数(每天OR 2.289;P = 0.013)。
尽管肝移植本身风险很高,但对急性肝衰竭患者仍能带来显著的生存益处。结果在很大程度上受移植时患者状况、器官可用性和术中管理的影响。尽管存在显著的死亡风险,但肝移植仍然是治疗因对乙酰氨基酚和毒蝇伞毒性导致急性肝衰竭的关键干预措施。